Literature DB >> 27639995

The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling.

Alexei Zelenev1, Elisa Long2, Alexander R Bazazi3, Adeeba Kamarulzaman4, Frederick L Altice5.   

Abstract

BACKGROUND: HIV is primarily concentrated among people who inject drugs (PWID) in Malaysia, where currently HIV prevention and treatment coverage is inadequate. To improve the targeting of interventions, we examined HIV clustering and the role that social networks and geographical distance play in influencing HIV transmission among PWID.
METHODS: Data were derived from a respondent-driven survey sample (RDS) collected during 2010 of 460 PWID in greater Kuala Lumpur. Analysis focused on socio-demographic, clinical, behavioural, and network information. Spatial probit models were developed based on a distinction between the influence of peers (individuals nominated through a recruitment network) and neighbours (residing a close distance to the individual). The models were expanded to account for the potential influence of the network formation.
RESULTS: Recruitment patterns of HIV-infected PWID clustered both spatially and across the recruitment networks. In addition, HIV-infected PWID were more likely to have peers and neighbours who inject with clean needles were HIV-infected and lived nearby (<5km), more likely to have been previously incarcerated, less likely to use clean needles (26.8% vs 53.0% of the reported injections, p<0.01), and have fewer recent injection partners (2.4 vs 5.4, p<0.01). The association between the HIV status of peers and neighbours remained significantly correlated even after controlling for unobserved variation related to network formation and sero-sorting.
CONCLUSION: The relationship between HIV status across networks and space in Kuala Lumpur underscores the importance of these factors for surveillance and prevention strategies, and this needs to be more closely integrated. RDS can be applied to identify injection network structures, and this provides an important mechanism for improving public health surveillance, accessing high-risk populations, and implementing risk-reduction interventions to slow HIV transmission.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Geography; HIV; Malaysia; People who inject drugs (PWID); Respondent-driven sampling; Social networks

Mesh:

Year:  2016        PMID: 27639995      PMCID: PMC5102779          DOI: 10.1016/j.drugpo.2016.08.008

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  27 in total

1.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

Review 2.  Review of sampling hard-to-reach and hidden populations for HIV surveillance.

Authors:  Robert Magnani; Keith Sabin; Tobi Saidel; Douglas Heckathorn
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

3.  Malaysia and harm reduction: the challenges and responses.

Authors:  Gary Reid; Adeeba Kamarulzaman; Sangeeta Kaur Sran
Journal:  Int J Drug Policy       Date:  2007-01-29

4.  An empirical comparison of respondent-driven sampling, time location sampling, and snowball sampling for behavioral surveillance in men who have sex with men, Fortaleza, Brazil.

Authors:  Carl Kendall; Ligia R F S Kerr; Rogerio C Gondim; Guilherme L Werneck; Raimunda Hermelinda Maia Macena; Marta Kerr Pontes; Lisa G Johnston; Keith Sabin; Willi McFarland
Journal:  AIDS Behav       Date:  2008-04-04

5.  Spatial recruitment bias in respondent-driven sampling: Implications for HIV prevalence estimation in urban heterosexuals.

Authors:  Samuel M Jenness; Alan Neaigus; Travis Wendel; Camila Gelpi-Acosta; Holly Hagan
Journal:  AIDS Behav       Date:  2014-12

6.  Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil.

Authors:  Lidiane Toledo; Cláudia T Codeço; Neilane Bertoni; Elizabeth Albuquerque; Monica Malta; Francisco I Bastos
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

Review 7.  What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.

Authors:  Louisa Degenhardt; Bradley M Mathers; Andrea L Wirtz; Daniel Wolfe; Adeeba Kamarulzaman; M Patrizia Carrieri; Steffanie A Strathdee; Kasia Malinowska-Sempruch; Michel Kazatchkine; Chris Beyrer
Journal:  Int J Drug Policy       Date:  2013-09-04

8.  Evaluation of respondent-driven sampling.

Authors:  Nicky McCreesh; Simon D W Frost; Janet Seeley; Joseph Katongole; Matilda N Tarsh; Richard Ndunguse; Fatima Jichi; Natasha L Lunel; Dermot Maher; Lisa G Johnston; Pam Sonnenberg; Andrew J Copas; Richard J Hayes; Richard G White
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

9.  Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users.

Authors:  Carl A Latkin; Valerie Forman; Amy Knowlton; Susan Sherman
Journal:  Soc Sci Med       Date:  2003-02       Impact factor: 4.634

Review 10.  Impact of HIV prevention programs on drug users in Malaysia.

Authors:  Adeeba Kamarulzaman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11       Impact factor: 3.731

View more
  2 in total

1.  Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Anna Meteliuk; Iryna Pykalo; Ruthanne Marcus; Tatiana Fomenko; Tatiana Prokhorova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2018-11-29

2.  A qualitative exploration of daily path and daily routine among people in Ukraine who inject drugs to understand associated harms.

Authors:  Jill Owczarzak; Jessie Chien; Karin Tobin; Alyona Mazhnaya; Olena Chernova; Tetiana Kiriazova
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.